Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial-Reference-Cited by-同舟云学术

Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial

Published:2020-11 Issue:11 Volume:5 Page:996-1007
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Kessoku Takaomi,Imajo Kento,Kobayashi Takashi,Ozaki Anna,Iwaki Michihiro,Honda Yasushi,Kato Takayuki,Ogawa Yuji,Tomeno Wataru,Kato Shingo,Higurashi Takuma,Yoneda Masato,Kirikoshi Hiroyuki,Kubota Kazumi,Taguri Masataka,Yamanaka Takeharu,Usuda Haruki,Wada Koichiro,Kobayashi Noritoshi,Saito Satoru,Nakajima Atsushi

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference42 articles.

1. NASH and HCC;Page;Clin Liver Dis,2009

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

3. Clinical feature of nonalcoholic steatohepatitis, associated with chronic constipation;Maevskaya;Eksp Klin Gastroenterol,2015

4. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease;Augustyn;Clin Exp Hepatol,2019

5. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease;Miele;Hepatology,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial;Nutrients;2024-07-28

2. Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship;Cureus;2024-07-03

3. Combined impact of alcohol consumption and metabolic syndrome on liver dysfunction in an elderly Chinese population;Diabetology & Metabolic Syndrome;2024-03-23

4. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease;World Journal of Gastroenterology;2024-02-21

5. The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial;Romanian Journal of Internal Medicine;2024-02-07